Geographic · Total consolidated revenue
China — Total consolidated revenue
Idexx Laboratories China — Total consolidated revenue remained flat by 0.0% to $8.99M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from $8.96M to $8.99M. Over 4 years (FY 2021 to FY 2025), China — Total consolidated revenue shows a downward trend with a -13.1% CAGR.
Analysis
Metric ID:
idxx_segment_china_total_consolidated_revenueHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $63.17M | $49.19M | $44.17M | $35.82M | $35.96M |
| YoY Change | — | -22.1% | -10.2% | -18.9% | +0.4% |
Range$35.82M – $63.17M
CAGR-13.1%
Avg YoY Growth-12.7%
Median YoY Growth-14.6%
Frequently Asked Questions
- What is Idexx Laboratories's china — total consolidated revenue?
- Idexx Laboratories (IDXX) reported china — total consolidated revenue of $8.99M in Q4 2025.
- How has Idexx Laboratories's china — total consolidated revenue changed year-over-year?
- Idexx Laboratories's china — total consolidated revenue increased by 0.4% year-over-year, from $8.96M to $8.99M.
- What is the long-term trend for Idexx Laboratories's china — total consolidated revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's china — total consolidated revenue has grown at a -13.1% compound annual growth rate (CAGR), from $63.17M to $35.96M.